Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ANABANAB
Showing 8 of 29 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ANAPTYSBIO INC

CITADEL ADVISORS LLC holds 394,373 shares of ANAB (ANAPTYSBIO INC), worth $26.6M as of 2026-Q2. The position was increased (+68.9% shares). ANAB represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$26.6M

Current Shares

394,373

Total Value Change

+$19.7M

Total Shares Change

+188,828

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
394,373
+68.9%
$26.6M0.0%$67.50
42
2026-Q1
Increased
233,450
+113.2%
$12.9M0.0%$52.83
45
2025-Q4
Increased
109,483
+313.5%
$5.3M0.0%$48.23
44
2025-Q3
Decreased
26,480
-77.6%
$810,8180.0%$23.27
0
2025-Q2
Decreased
118,286
-68.3%
$2.6M0.0%$22.47
0
2025-Q1
Increased
372,569
+114.5%
$6.9M0.0%$18.95
44
2024-Q4
Decreased
173,727
-15.5%
$2.3M0.0%$13.22
0
2024-Q3
Increased
205,545
+153.8%
$6.9M0.0%$31.87
44

Other major holders of ANAB: ADAGE CAPITAL PARTNERS GP, L.L.C., BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used